Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration

H.H. Hansen; I. Lastres-Becker; F. Berrendero; J. Manzanares; J. Javier Fernández-Ruiz; P.C. Schmid; H.H.O. Schmid; P. Bittigau; C. Ikonomidou; Harald S. Hansen

doi:10.1046/j.1471-4159.2001.00542.x

Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration

H.H. Hansen, I. Lastres-Becker, F. Berrendero, J. Manzanares, J. Javier Fernández-Ruiz, P.C. Schmid, H.H.O. Schmid, P. Bittigau, C. Ikonomidou, Harald S. Hansen

197 Citations (Scopus)

Abstract

Endogenous cannabinoid receptor ligands (endocannabinoids) may rescue neurons from glutamate excitotoxicity. As these substances also accumulate in cultured immature neurons following neuronal damage, elevated endocannabinoid concentrations may be interpreted as a putative neuroprotective response. However, it is not known how glutamatergic insults affect in vivo endocannabinoid homeostasis, i.e. N-arachidonoylethanolamine (anandamide) and 2-arachidonoylglycerol (2-AG), as well as other constituents of their lipid families, N-acylethanolamines (NAEs) and 2-monoacylglycerols (2-MAGs), respectively. Here we employed three in vivo neonatal rat models characterized by widespread neurodegeneration as a consequence of altered glutamatergic neurotransmission and assessed changes in endocannabinoid homeostasis. A 46-fold increase of cortical NAE concentrations (anandamide, 13-fold) was noted 24 h after intracerebral NMDA injection, while less severe insults triggered by mild concussive head trauma or NMDA receptor blockade produced a less pronounced NAE accumulation. By contrast, levels of 2-AG and other 2-MAGs were virtually unaffected by the insults employed, rendering it likely that key enzymes in biosynthetic pathways of the two different endocannabinoid structures are not equally associated to intracellular events that cause neuronal damage in vivo. Analysis of cannabinoid CB receptor mRNA expression and binding capacity revealed that cortical subfields exhibited an up-regulation of these parameters following mild concussive head trauma and exposure to NMDA receptor blockade. This may suggest that mild to moderate brain injury may trigger elevated endocannabinoid activity via concomitant increase of anandamide levels, but not 2-AG, and CB receptor density.

Original language	English
Journal	Journal of Neurochemistry
Volume	78
Issue number	6
Pages (from-to)	1415-1427
Number of pages	13
ISSN	0022-3042
DOIs	https://doi.org/10.1046/j.1471-4159.2001.00542.x
Publication status	Published - 1 Jan 2001

Access to Document

10.1046/j.1471-4159.2001.00542.x

Cite this

@article{fda6d79b1bfe46749916e1fd067fd6b0,

title = "Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration",

abstract = "Endogenous cannabinoid receptor ligands (endocannabinoids) may rescue neurons from glutamate excitotoxicity. As these substances also accumulate in cultured immature neurons following neuronal damage, elevated endocannabinoid concentrations may be interpreted as a putative neuroprotective response. However, it is not known how glutamatergic insults affect in vivo endocannabinoid homeostasis, i.e. N-arachidonoylethanolamine (anandamide) and 2-arachidonoylglycerol (2-AG), as well as other constituents of their lipid families, N-acylethanolamines (NAEs) and 2-monoacylglycerols (2-MAGs), respectively. Here we employed three in vivo neonatal rat models characterized by widespread neurodegeneration as a consequence of altered glutamatergic neurotransmission and assessed changes in endocannabinoid homeostasis. A 46-fold increase of cortical NAE concentrations (anandamide, 13-fold) was noted 24 h after intracerebral NMDA injection, while less severe insults triggered by mild concussive head trauma or NMDA receptor blockade produced a less pronounced NAE accumulation. By contrast, levels of 2-AG and other 2-MAGs were virtually unaffected by the insults employed, rendering it likely that key enzymes in biosynthetic pathways of the two different endocannabinoid structures are not equally associated to intracellular events that cause neuronal damage in vivo. Analysis of cannabinoid CB receptor mRNA expression and binding capacity revealed that cortical subfields exhibited an up-regulation of these parameters following mild concussive head trauma and exposure to NMDA receptor blockade. This may suggest that mild to moderate brain injury may trigger elevated endocannabinoid activity via concomitant increase of anandamide levels, but not 2-AG, and CB receptor density.",

author = "H.H. Hansen and I. Lastres-Becker and F. Berrendero and J. Manzanares and {Javier Fern{\'a}ndez-Ruiz}, J. and P.C. Schmid and H.H.O. Schmid and P. Bittigau and C. Ikonomidou and Hansen, {Harald S.}",

year = "2001",

month = jan,

day = "1",

doi = "10.1046/j.1471-4159.2001.00542.x",

language = "English",

volume = "78",

pages = "1415--1427",

journal = "Journal of Neurochemistry",

issn = "0022-3042",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration

AU - Hansen, H.H.

AU - Lastres-Becker, I.

AU - Berrendero, F.

AU - Manzanares, J.

AU - Javier Fernández-Ruiz, J.

AU - Schmid, P.C.

AU - Schmid, H.H.O.

AU - Bittigau, P.

AU - Ikonomidou, C.

AU - Hansen, Harald S.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Endogenous cannabinoid receptor ligands (endocannabinoids) may rescue neurons from glutamate excitotoxicity. As these substances also accumulate in cultured immature neurons following neuronal damage, elevated endocannabinoid concentrations may be interpreted as a putative neuroprotective response. However, it is not known how glutamatergic insults affect in vivo endocannabinoid homeostasis, i.e. N-arachidonoylethanolamine (anandamide) and 2-arachidonoylglycerol (2-AG), as well as other constituents of their lipid families, N-acylethanolamines (NAEs) and 2-monoacylglycerols (2-MAGs), respectively. Here we employed three in vivo neonatal rat models characterized by widespread neurodegeneration as a consequence of altered glutamatergic neurotransmission and assessed changes in endocannabinoid homeostasis. A 46-fold increase of cortical NAE concentrations (anandamide, 13-fold) was noted 24 h after intracerebral NMDA injection, while less severe insults triggered by mild concussive head trauma or NMDA receptor blockade produced a less pronounced NAE accumulation. By contrast, levels of 2-AG and other 2-MAGs were virtually unaffected by the insults employed, rendering it likely that key enzymes in biosynthetic pathways of the two different endocannabinoid structures are not equally associated to intracellular events that cause neuronal damage in vivo. Analysis of cannabinoid CB receptor mRNA expression and binding capacity revealed that cortical subfields exhibited an up-regulation of these parameters following mild concussive head trauma and exposure to NMDA receptor blockade. This may suggest that mild to moderate brain injury may trigger elevated endocannabinoid activity via concomitant increase of anandamide levels, but not 2-AG, and CB receptor density.

AB - Endogenous cannabinoid receptor ligands (endocannabinoids) may rescue neurons from glutamate excitotoxicity. As these substances also accumulate in cultured immature neurons following neuronal damage, elevated endocannabinoid concentrations may be interpreted as a putative neuroprotective response. However, it is not known how glutamatergic insults affect in vivo endocannabinoid homeostasis, i.e. N-arachidonoylethanolamine (anandamide) and 2-arachidonoylglycerol (2-AG), as well as other constituents of their lipid families, N-acylethanolamines (NAEs) and 2-monoacylglycerols (2-MAGs), respectively. Here we employed three in vivo neonatal rat models characterized by widespread neurodegeneration as a consequence of altered glutamatergic neurotransmission and assessed changes in endocannabinoid homeostasis. A 46-fold increase of cortical NAE concentrations (anandamide, 13-fold) was noted 24 h after intracerebral NMDA injection, while less severe insults triggered by mild concussive head trauma or NMDA receptor blockade produced a less pronounced NAE accumulation. By contrast, levels of 2-AG and other 2-MAGs were virtually unaffected by the insults employed, rendering it likely that key enzymes in biosynthetic pathways of the two different endocannabinoid structures are not equally associated to intracellular events that cause neuronal damage in vivo. Analysis of cannabinoid CB receptor mRNA expression and binding capacity revealed that cortical subfields exhibited an up-regulation of these parameters following mild concussive head trauma and exposure to NMDA receptor blockade. This may suggest that mild to moderate brain injury may trigger elevated endocannabinoid activity via concomitant increase of anandamide levels, but not 2-AG, and CB receptor density.

UR - http://www.scopus.com/inward/record.url?scp=0034801539&partnerID=8YFLogxK

U2 - 10.1046/j.1471-4159.2001.00542.x

DO - 10.1046/j.1471-4159.2001.00542.x

M3 - Journal article

AN - SCOPUS:0034801539

SN - 0022-3042

VL - 78

SP - 1415

EP - 1427

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

IS - 6

ER -

Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration

Abstract

Access to Document

Other files and links

Fingerprint

Cite this